Cases

C3.ai, Inc. (NYSE: AI)

C3.AI INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of C3.ai, Inc. – AI

Magellan Midstream Partners, L.P. (NYSE: MMP)

MAGELLAN MIDSTREAM INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Magellan Midstream Partners, L.P. – MMP

Icahn Enterprises L.P. (NasdaqGS: IEP)

ICAHN ENTERPRISES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Icahn Enterprises L.P. – IEP

Beyond Meat, Inc. (NasdaqGS: BYND)

BEYOND MEAT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Beyond Meat, Inc. – BYND

Western Digital Corporation (NasdaqGS: WDC)

WESTERN DIGITAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Western Digital Corporation – WDC

Home Point Capital Inc. (NasdaqGS: HMPT)

HOME POINT CAPITAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Home Point Capital Inc. – HMPT

Livent Corporation (NYSE: LTHM)

LIVENT CORPORATION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Livent Corporation – LTHM

Franchise Group, Inc. (NasdaqGM: FRG)

FRANCHISE GROUP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Franchise Group, Inc. – FRG

CTI BioPharma Corp. (NasdaqCM: CTIC)

CTI BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. – CTIC

Arconic Corporation (NYSE: ARNC)

ARCONIC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arconic Corporation – ARNC

Amedisys, Inc. (NasdaqGS: AMED)

AMEDISYS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. – AMED

IVERIC bio, Inc. (NasdaqGS: ISEE)

IVERIC BIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. – ISEE

Midwest Holding Inc. (NasdaqCM: MDWT)

MIDWEST HOLDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Midwest Holding Inc. – MDWT

Medical Properties Trust, Inc. (NYSE: MPW)

MEDICAL PROPERTIES TRUST INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Medical Properties Trust, Inc. – MPW

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)

SPECTRUM PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. – SPPI

LivePerson, Inc. (NasdaqGS: LPSN)

LIVEPERSON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LivePerson, Inc. – LPSN

Charah Solutions, Inc. (OTC: CHRA)

CHARAH SOLUTIONS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Charah Solutions, Inc. – CHRA

Prometheus Biosciences, Inc. (NasdaqGS: RXDX)

PROMETHEUS BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. – RXDX

Satsuma Pharmaceuticals, Inc. (NasdaqGM: STSA)

SATSUMA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. – STSA

KSF News, Updates, & Insights

Recent Victories

KSF Defeats Motion to Dismiss in Velodyne Securities Litigation

The Hon. Susan Illston, United States District Judge for the Northern District of California, entered an Order partially denying Defendants’ motion to dismiss Lead Plaintiffs’ securities fraud complaint against corporate Defendant Velodyne Lidar, Inc. and individual Defendants Anand Gopalan, James Graf, and Michael Dee.